These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 28073122)
1. Central μ-Opioidergic System Activation Evoked by Heavy and Severe-Intensity Cycling Exercise in Humans: a Pilot Study Using Positron Emission Tomography with 11C-Carfentanil. Hiura M; Sakata M; Ishii K; Toyohara J; Oda K; Nariai T; Ishiwata K Int J Sports Med; 2017 Jan; 38(1):19-26. PubMed ID: 28073122 [TBL] [Abstract][Full Text] [Related]
2. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. Zubieta JK; Ketter TA; Bueller JA; Xu Y; Kilbourn MR; Young EA; Koeppe RA Arch Gen Psychiatry; 2003 Nov; 60(11):1145-53. PubMed ID: 14609890 [TBL] [Abstract][Full Text] [Related]
3. Opioid Release after High-Intensity Interval Training in Healthy Human Subjects. Saanijoki T; Tuominen L; Tuulari JJ; Nummenmaa L; Arponen E; Kalliokoski K; Hirvonen J Neuropsychopharmacology; 2018 Jan; 43(2):246-254. PubMed ID: 28722022 [TBL] [Abstract][Full Text] [Related]
4. Temperament trait Harm Avoidance associates with μ-opioid receptor availability in frontal cortex: a PET study using [(11)C]carfentanil. Tuominen L; Salo J; Hirvonen J; Någren K; Laine P; Melartin T; Isometsä E; Viikari J; Raitakari O; Keltikangas-Järvinen L; Hietala J Neuroimage; 2012 Jul; 61(3):670-6. PubMed ID: 22484309 [TBL] [Abstract][Full Text] [Related]
5. Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. Kennedy SE; Koeppe RA; Young EA; Zubieta JK Arch Gen Psychiatry; 2006 Nov; 63(11):1199-208. PubMed ID: 17088500 [TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans. Love TM; Stohler CS; Zubieta JK Arch Gen Psychiatry; 2009 Oct; 66(10):1124-34. PubMed ID: 19805703 [TBL] [Abstract][Full Text] [Related]
7. Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans. Scott DJ; Domino EF; Heitzeg MM; Koeppe RA; Ni L; Guthrie S; Zubieta JK Neuropsychopharmacology; 2007 Feb; 32(2):450-7. PubMed ID: 17091130 [TBL] [Abstract][Full Text] [Related]
8. Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil. Heinz A; Reimold M; Wrase J; Hermann D; Croissant B; Mundle G; Dohmen BM; Braus DF; Schumann G; Machulla HJ; Bares R; Mann K Arch Gen Psychiatry; 2005 Jan; 62(1):57-64. PubMed ID: 15630073 [TBL] [Abstract][Full Text] [Related]
9. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Scott DJ; Stohler CS; Egnatuk CM; Wang H; Koeppe RA; Zubieta JK Arch Gen Psychiatry; 2008 Feb; 65(2):220-31. PubMed ID: 18250260 [TBL] [Abstract][Full Text] [Related]
10. Preparation and biodistribution in mice of [11C]carfentanil: a radiopharmaceutical for studying brain mu-opioid receptors by positron emission tomography. Saji H; Tsutsumi D; Magata Y; Iida Y; Konishi J; Yokoyama A Ann Nucl Med; 1992 Feb; 6(1):63-7. PubMed ID: 1325823 [TBL] [Abstract][Full Text] [Related]
11. [11C]Carfentanil Binds Preferentially to μ-Opioid Receptor Subtype 1 Compared to Subtype 2. Eriksson O; Antoni G Mol Imaging; 2015; 14():476-83. PubMed ID: 26461068 [TBL] [Abstract][Full Text] [Related]
12. Mu-opioid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence. Bencherif B; Wand GS; McCaul ME; Kim YK; Ilgin N; Dannals RF; Frost JJ Biol Psychiatry; 2004 Feb; 55(3):255-62. PubMed ID: 14744466 [TBL] [Abstract][Full Text] [Related]
13. Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET). Bencherif B; Fuchs PN; Sheth R; Dannals RF; Campbell JN; Frost JJ Pain; 2002 Oct; 99(3):589-598. PubMed ID: 12406535 [TBL] [Abstract][Full Text] [Related]
14. Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving. Gorelick DA; Kim YK; Bencherif B; Boyd SJ; Nelson R; Copersino M; Endres CJ; Dannals RF; Frost JJ Biol Psychiatry; 2005 Jun; 57(12):1573-82. PubMed ID: 15953495 [TBL] [Abstract][Full Text] [Related]
15. What to learn from in vivo opioidergic brain imaging? Sprenger T; Berthele A; Platzer S; Boecker H; Tölle TR Eur J Pain; 2005 Apr; 9(2):117-21. PubMed ID: 15737798 [TBL] [Abstract][Full Text] [Related]
16. Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system. Jassar H; Nascimento TD; Kaciroti N; DosSantos MF; Danciu T; Koeppe RA; Smith YR; Bigal ME; Porreca F; Casey KL; Zubieta JK; DaSilva AF Neuroimage Clin; 2019; 23():101905. PubMed ID: 31279240 [TBL] [Abstract][Full Text] [Related]
17. The relationship between naloxone-induced cortisol and mu opioid receptor availability in mesolimbic structures is disrupted in alcohol dependent subjects. Wand GS; Weerts EM; Kuwabara H; Wong DF; Xu X; McCaul ME Alcohol; 2012 Sep; 46(6):511-7. PubMed ID: 22717196 [TBL] [Abstract][Full Text] [Related]
18. The runner's high: opioidergic mechanisms in the human brain. Boecker H; Sprenger T; Spilker ME; Henriksen G; Koppenhoefer M; Wagner KJ; Valet M; Berthele A; Tolle TR Cereb Cortex; 2008 Nov; 18(11):2523-31. PubMed ID: 18296435 [TBL] [Abstract][Full Text] [Related]